ERcast: Clinical Perspectives Podcast Preview

Subscription Required

Dogma Debunking & Scary Spiders

Shirley Shao, MD, Geoffrey Comp, DO, FACEP, Tiffany Proffitt, DO, Anne Steckowych, APRN, Brett Murray, MD, and Manpreet Singh, MD

Sign in or Subscribe to listen.
5 starson Spotify
Sign in or Subscribe to view.Sign in or Subscribe to view.

The summary below is from an episode of ERcast: Clinical Perspectives

Arachnid envenomation is a syndrome-recognition problem: black widow and bark scorpion exposures are primarily neurotoxic, while brown recluse bites cause progressive cutaneous injury with only rare systemic hemolysis. High-value emergency care starts with pretest probability, because reflexive lab testing often prolongs ED length of stay and triggers false positives without improving outcomes.

Arachnid Envenomation Recognition and Care

  • Syndrome first approach: Geography and bedside toxidrome matter more than species identification, because most presumed “spider bites” are not true bites and management is driven by the clinical pattern.
  • Black widow neurotoxicity: Alpha-latrotoxin causes massive presynaptic neurotransmitter release, producing diffuse muscle cramping and abdominal rigidity that can convincingly mimic an acute abdomen.
  • Brown recluse lesion pattern: The classic recluse lesion evolves over about 24 hours into a red, white, and blue appearance, then may progress over days to ulceration and necrosis.
  • Systemic loxoscelism red flags: Hemolysis, hemorrhagic bullae, AKI, and a DIC-like picture are the uncommon but dangerous recluse complications, a distinction worth hearing in the chapter.
  • Bark scorpion severe findings: Tongue fasciculations, opsoclonus, hypersalivation, and myoclonus point to clinically important envenomation, especially in children who can look dramatically toxic.
  • Antivenom decision points: Supportive care remains first-line, while antivenom is reserved for select severe widow or bark scorpion cases with toxicology input. We get into the bedside selection nuances in the episode.

Reducing Low-Value Testing in the ED

  • Purpose-driven test ordering: Every lab should have a clear role in management, disposition, or counseling; if an abnormal result would not change anything, the test is probably low value.
  • Downstream harm cascade: Low-yield testing creates false positives, incidental findings, extra imaging, avoidable admissions, and longer length of stay without necessarily improving outcomes.
  • Pulmonary embolism restraint: In low-risk patients who are Wells and PERC negative, a reflexive D-dimer can start an unnecessary path toward CTPA, radiation, and incidentalomas.
  • Psych clearance myth: Routine laboratory testing for low-risk psychiatric patients is generally unnecessary when history and physical examination do not suggest a medical cause for symptoms.
  • Trauma coagulation overuse: Healthy trauma patients without suspected bleeding usually do not need routine coagulation studies; reserve them for cases where the result will alter care.
  • Shared decision framework: Asking what the patient fears most and hopes to accomplish often reveals that reassurance, follow-up, or social support matters more than another lab. We lay out practical phrasing on the show.

Subscribe to ERcast: Clinical Perspectives to listen to the episode.

References:

  1. Isbister GK, Bawaskar HS. Scorpion envenomation. N Engl J Med. 2014 Jul 31;371(5):457-63. PMID: 25075837.
  2. Lopes PH, Squaiella-Baptistão CC, Marques MOT, Tambourgi DV. Clinical aspects, diagnosis and management of Loxosceles spider envenomation: literature and case review. Arch Toxicol. 2020 May;94(5):1461-1477. Epub 2020 Mar 30. PMID: 32232511.

Faculty